Healthy adult
Conditions
Interventions
Intake of test foods for one week (1 capsules/ day)
Intake of placebo foods for one week (1 capsules/ day)
Sponsors
Kagoshima Immaculate Heart University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy adult males and females between 20 to 64 years (2) BMI: less than 30 kg/m2 (3) Subjects who have received sufficient explanation about the purpose and content of the examination, have the ability to consent, have a good understanding, volunteered to participate and agreed to participate in the examination in writing
Exclusion criteria
Exclusion criteria: (1) Subjects who were diagnosed with liver disease, kidney disease, gastrointestinal disease, heart disease, diabetes, or other diseases that may affect the results of this study, or who have a history of surgery (2) Subjects who indicate abnormal parameter in liver or kidney function (3) Subjects with a disease currently under treatment (4) Subjects with anemia (5) Subjects who detect abnormal values by blood test (6) Subjects who determine ineligible by principal investigator (7) Subjects with drug or food allergies (8) Subjects who play high intensity sports and/or are on a diet (9) Subjects who can't stop using functional foods (including Food for Specified Health Uses or Foods with Function Claims) and/or Specified quasi-drugs during the current study periods (10) Subjects who are under treatment with medications (including OTC or prescribed medication) (11) Subjects who drink excessive alcohol, or who can't stop drinking from one day before each measurement (12) Subjects with smoking habit (13) Subjects with irregular life patterns and lifestyle of reversal of day and night (14) Subjects who have a habit of excessive eating and drinking (15) Subject who has been pregnant or subject who have a plan to become pregnant or breast feed during the study period (16) Subjects who is participating in the other study or planning to participate during the study period (17) Subjects who has taken the blood sampling more than 200 mL within 1 month, or plan the blood sampling during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exhaled gas measurement Assess these at screening (before intake), at one week after intake | — |
Countries
Japan
Contacts
Public ContactNozaki Tsutomu
BHN Co., Ltd. Research and Development Dept.
Outcome results
None listed